These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37630311)

  • 41. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation.
    Wang Z; Sun L; Xu Y; Liang P; Xu K; Huang J
    J Transl Med; 2023 Aug; 21(1):579. PubMed ID: 37641144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacophore-based virtual screening and
    Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN
    J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations.
    Rafiq H; Hu J; Hakami MA; Hazazi A; Alamri MA; Alkhatabi HA; Mahmood A; Alotaibi BS; Wadood A; Huang X
    Sci Rep; 2023 Nov; 13(1):20147. PubMed ID: 37978263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In silico analysis of marine natural product for protein arginine methyltransferase 5(PRMT5) inhibitors based on pharmacophore and molecular docking.
    Luo L; Tan H; Liao Y
    J Biomol Struct Dyn; 2023; 41(22):13180-13197. PubMed ID: 36856049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of novel PARP-1 inhibitors using tandem
    Bhatnagar A; Nath V; Kumar N; Kumar V
    J Biomol Struct Dyn; 2024 Apr; 42(7):3396-3409. PubMed ID: 37216358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation.
    Halim SA; Sikandari AG; Khan A; Wadood A; Fatmi MQ; Csuk R; Al-Harrasi A
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling.
    Albayati S; Uba AI; Yelekçi K
    Mol Divers; 2022 Apr; 26(2):1005-1016. PubMed ID: 33846894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and development of novel potential inhibitors of the human USP21 enzyme using a pharmacophore-based virtual screening technique.
    Roy A; Luharuka S; Paul I; Ray S
    J Mol Recognit; 2023 Jul; 36(7):e3023. PubMed ID: 37096811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade.
    Saroj Devi N; Shanmugam R; Ghorai J; Ramanan M; Anbarasan P; Doble M
    Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and
    Lakshmanan K; T K P; K Pai SR; Rajagopal K; Byran G
    J Biomol Struct Dyn; 2022; 40(21):11320-11338. PubMed ID: 34463213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
    Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P
    Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches.
    Saddala MS; Huang H
    J Transl Med; 2019 Jul; 17(1):215. PubMed ID: 31266509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of potential inhibitors against
    Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
    J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches.
    Selvakumar R; Anantha Krishnan D; Ramakrishnan C; Velmurugan D; Gunasekaran K
    J Biomol Struct Dyn; 2020 Feb; 38(3):682-696. PubMed ID: 30806580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Combination of Pharmacophore Generation, Ligand-based Virtual Screening, Atom-based 3D-QSAR, and Molecular Docking Studies on Febuxostat-based Amides Analogues as Anti-inflammatory Agents.
    Chitre T; Bhatambrekar A; Hirode P; Thorat S; Hajare SG; Garud D; Jagdale S; Asgaonkar K
    Curr Drug Discov Technol; 2024 Mar; ():. PubMed ID: 38485685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of novel heterocyclic amide-based inhibitors: an integrative
    Fakhar Z; Hejazi L; Tabatabai SA; Munro OQ
    J Biomol Struct Dyn; 2022 Sep; 40(15):7114-7128. PubMed ID: 33650467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
    Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
    J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.